SCHEMBL4898112

SCHEMBL4898112

CCc1ccc(SCCNS(=O)(=O)c2ccc(CC)c(C(=O)O)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.48
TSHR P16473 6/20 0.48
HSD17B10 Q99714 1/20 0.48
LMNA P02545 5/20 0.47
HTT P42858 3/20 0.47
MAPT P10636 3/20 0.46
GAA P10253 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
MAPK1 P28482 1/20 0.42
METAP2 P50579 2/20 0.41
BCL2 P10415 1/20 0.40
BCL2L1 Q07817 1/20 0.40
MCL1 Q07820 1/20 0.40
BCL2A1 Q16548 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4900064 0.90 ALDH1A1 (0.52) ALDH1A1TSHRHSD17B10LMNAHTT
SCHEMBL4902479 0.90 LMNA (0.55) ALDH1A1TSHRHSD17B10LMNAHTT
SCHEMBL4900985 0.88 ALDH1A1 (0.47) ALDH1A1TSHRHSD17B10LMNAHTT
SCHEMBL4906026 0.87 ALDH1A1 (0.49) ALDH1A1TSHRHSD17B10LMNAHTT
SCHEMBL4895503 0.87 ALDH1A1 (0.46) ALDH1A1TSHRHSD17B10LMNAHTT
SCHEMBL4905841 0.84 ALDH1A1 (0.45) ALDH1A1TSHRHSD17B10LMNAHTT
SCHEMBL4905287 0.84 LMNA (0.49) ALDH1A1TSHRHSD17B10LMNAHTT
SCHEMBL4894500 0.83 ALDH1A1 (0.55) ALDH1A1TSHRHSD17B10LMNAHTT
SCHEMBL4902919 0.80 ALDH1A1 (0.50) ALDH1A1TSHRHSD17B10LMNAHTT
SCHEMBL4906147 0.79 ALDH1A1 (0.45) ALDH1A1TSHRHSD17B10LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD ALDH1A1 2664/4885TSHR 412/4885HSD17B10 434/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885HSD17B10 434/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ALDH1A1 2956/4885TSHR 400/4885HSD17B10 434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.